Hallett Concrete will receive up to $20 million for a $109 million project to turn industrial waste into green cement products.
The project will take industrial waste from three existing mineral processing operations into low carbon cement products, replace imports and secure low carbon cements for the Australian construction industry.
It will include integrating a slag granulating plant at the Whyalla Steelworks, a grinding, processing and distribution hub at Port Augusta, and a product receival, blending and distribution hub at Port Adelaide.
The project is one of seven in South Australia to share in more than $48 million of funding through Round 2 of the Integration and Translation Streams of the Modern Manufacturing Initiative.
Angus Taylor, Minister for Industry, Energy and Emissions Reduction, said the funding would bolster the state’s thriving manufacturing sector and unlock further significant investment.
“South Australia has a long and proud history in manufacturing. This funding is a big win for jobs and another vote of confidence in South Australia’s advanced manufacturing capability,” Taylor said.
“We are backing these businesses to turn good ideas into commercial success stories and build critical capability for the future. Our $2.5 billion Modern Manufacturing Strategy is all about helping home-grown manufacturers break into new markets and turn innovative ideas into a reality.
Other business to share in the funding include Orora, which will receive up to $12.5 million to construct a new low carbon clean energy glass melting furnace to replace the current G3 glass gas/air red furnace. The project will be the first oxygen red glass furnace in Australia and is expected to create more than 150 new jobs and deliver low carbon wine and beer glass containers to support the Australian food and beverage industry.
Bickford’s Australia will receive up to $2.95 million to establish a new manufacturing facility dedicated to the production of highly sensitive beverage product categories such as dairy, electrolyte replenishment, prebiotics, protein milk and ready to feed baby formula.
Mayne Pharmaceuticals will receive up to $4.8 million to expand its advanced manufacturing capability and ensure the Salisbury site remains one of Australia’s leading solid oral dose manufacturing facilities.
For more information, visit: www.liberal.org.au
Related stories:
$1.3B Modern Manufacturing Initiative backs recycling
$1.3 billion in grants for waste solutions